Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biontech Se ADR (NQ: BNTX )

96.95 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,589
Open 96.95
Bid (Size) 97.36 (1)
Ask (Size) 97.69 (2)
Prev. Close 96.95
Today's Range 96.95 - 96.95
52wk Range 85.21 - 125.83
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In Your Portfolio?
Top-performing stocks last week were FSLR, MRNA, ELF, NVDA, IP, ADI, FLEX, LOGI, BNTX, and MNDY, boosted by positive news and analyst targets. 
Via Benzinga
Why Vaccine Stocks Rallied This Week
A bird flu outbreak could spur demand for vaccines from these key players, but is it likely? 
Via The Motley Fool

Performance

YTD
-13.70%
-13.70%
1 Month
+10.06%
+10.06%
3 Month
+3.17%
+3.17%
6 Month
-1.90%
-1.90%
1 Year
-14.20%
-14.20%

More News

Read More
Critical Insights From BioNTech Analyst Ratings: What You Need To Know
Via Benzinga
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb
Via Benzinga
Exposures COVID-19
Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For BioNTech
Via Benzinga
Assessing BioNTech: Insights From 11 Financial Analysts
Via Benzinga
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
From BioNTech SE
Via GlobeNewswire
3 Blue-Chip Stocks Set to Triple Soon
Via InvestorPlace
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
From BioNTech SE
Via GlobeNewswire
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Via Benzinga
BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
BNTX Stock Earnings: BioNTech Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
What's Going With BioNTech Stock On Monday?
Via Benzinga
BioNTech Slides After Reporting Losses As Covid Vaccine Sales Take A Hit
Via Investor's Business Daily
Exposures COVID-19
BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Wall Street Looks To Extend Rally Amid Caution Over Fed Speeches, More Earnings: Why This Analyst Thinks Bull Market Is Still 'Quite Young'
Via Benzinga
Topics Economy
Exposures Interest Rates
BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
From BioNTech SE
Via GlobeNewswire
Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report
Via Benzinga
Topics Stocks
Exposures US Equities
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Via Benzinga
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
Via Benzinga
Topics Intellectual Property Lawsuit
Exposures COVID-19 Financial Intellectual Property
What's Going On With Pfizer Stock On Thursday?
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
From BioNTech SE
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.